Sun Pharmaceuticals
Sun Pharma to buy Glaxo’s Australian opiates business
03 Mar 2015
The deal comes as Sun wraps up the last leg of its $ 4-billion proposal to buy troubled generic drugs maker Ranbaxy in India
Suzlon Energy confirms 23% stake sale to Sun’s Shanghvi
14 Feb 2015
Dilip Shanghvi and others on Saturday made an open offer to shareholders of Suzlon Energy immediately after announcing that it would invest Rs1,800 crore in the company
Sun’s Shanghvi reported in talks with Tanti for Suzlon stake
13 Feb 2015
Sun Pharmaceuticals founder Dilip Shanghvi and Tulsi Tanti of Suzlon Energy are in advanced talks for a multi-layer deal to eventually give the pharma baron's family a stake in the debt-laden wind turbine maker
Sun Pharma buyout of Ranbaxy gets conditional US nod
31 Jan 2015
Fearing that the $4-billion deal would be anti-competitive, the FTC has stipulated that Sun sell its interest in a generic anti-bacterial medicine
Sun Pharma, Ranbaxy merger deal gets conditional CCI nod
09 Dec 2014
The CCI has asked the two companies to sell off seven brands with combined sales of less than Rs50 crore and market share of 60 to 80 per cent, which the regulator felt, would adversely affect competition
Sun-Ranbaxy merger: competition panel demands more details
28 Aug 2014
This is probably the first instance where the fair trade watchdog has ordered a public scrutiny of a proposed merger and acquisition deal to ensure compliance to fair trade regulation
